NCT03007927View on ClinicalTrials.gov

Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

June 29, 2017

Conditions
Pain, Postoperative
Interventions
DRUG

Bupivacaine-Dexamethasone

Bupivacaine 1,5 mg/kg-Dexamethasone 2ml 8 mg

DRUG

Bupivacaine- physiological solution

Bupivacaine 1,5 mg/kg- physiological solution

Trial Locations (1)

C1199ABB

Hospital Italiano de Buenos Aires, Peron 4190, Buenos Aires

All Listed Sponsors
collaborator

Sebastián Roche, MD

UNKNOWN

collaborator

Santiago Bertone, MD

UNKNOWN

collaborator

Claudio Brandi, MD

UNKNOWN

lead

SEBASTIAN ROCHE

OTHER

NCT03007927 - Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh | Biotech Hunter | Biotech Hunter